vs

Side-by-side financial comparison of GEN Restaurant Group, Inc. (GENK) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

GEN Restaurant Group, Inc. is the larger business by last-quarter revenue ($49.7M vs $44.6M, roughly 1.1× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). GEN Restaurant Group, Inc. runs the higher net margin — -3.8% vs -90.4%, a 86.6% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -9.0%). GEN Restaurant Group, Inc. produced more free cash flow last quarter ($-5.6M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -1.0%).

Gen Korean BBQ is an American chain of all-you-can-eat Korean barbecue restaurants mainly concentrated around the Western U.S. It opened in 2011, and has since grown to 43 locations as of 2024.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

GENK vs PACB — Head-to-Head

Bigger by revenue
GENK
GENK
1.1× larger
GENK
$49.7M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+22.8% gap
PACB
13.8%
-9.0%
GENK
Higher net margin
GENK
GENK
86.6% more per $
GENK
-3.8%
-90.4%
PACB
More free cash flow
GENK
GENK
$14.3M more FCF
GENK
$-5.6M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-1.0%
GENK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENK
GENK
PACB
PACB
Revenue
$49.7M
$44.6M
Net Profit
$-1.9M
$-40.4M
Gross Margin
37.1%
Operating Margin
-24.5%
-92.3%
Net Margin
-3.8%
-90.4%
Revenue YoY
-9.0%
13.8%
Net Profit YoY
-821.4%
-1802.7%
EPS (diluted)
$-0.37
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENK
GENK
PACB
PACB
Q4 25
$49.7M
$44.6M
Q3 25
$50.4M
$38.4M
Q2 25
$55.0M
$39.8M
Q1 25
$57.3M
$37.2M
Q4 24
$54.7M
$39.2M
Q3 24
$49.1M
$40.0M
Q2 24
$53.9M
$36.0M
Q1 24
$50.8M
$38.8M
Net Profit
GENK
GENK
PACB
PACB
Q4 25
$-1.9M
$-40.4M
Q3 25
$-566.0K
$-38.0M
Q2 25
$-261.0K
$-41.9M
Q1 25
$-301.0K
$-426.1M
Q4 24
$-206.0K
$2.4M
Q3 24
$25.0K
$-60.7M
Q2 24
$277.0K
$-173.3M
Q1 24
$496.0K
$-78.2M
Gross Margin
GENK
GENK
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
GENK
GENK
PACB
PACB
Q4 25
-24.5%
-92.3%
Q3 25
-7.4%
-101.1%
Q2 25
-3.4%
-112.8%
Q1 25
-3.8%
-1154.5%
Q4 24
-2.4%
-390.1%
Q3 24
0.2%
-160.3%
Q2 24
3.0%
-488.3%
Q1 24
0.2%
-209.6%
Net Margin
GENK
GENK
PACB
PACB
Q4 25
-3.8%
-90.4%
Q3 25
-1.1%
-98.9%
Q2 25
-0.5%
-105.4%
Q1 25
-0.5%
-1146.8%
Q4 24
-0.4%
6.0%
Q3 24
0.1%
-151.9%
Q2 24
0.5%
-481.3%
Q1 24
1.0%
-201.4%
EPS (diluted)
GENK
GENK
PACB
PACB
Q4 25
$-0.37
$-0.11
Q3 25
$-0.11
$-0.13
Q2 25
$-0.05
$-0.14
Q1 25
$-0.06
$-1.44
Q4 24
$-0.05
$-0.44
Q3 24
$0.01
$-0.22
Q2 24
$0.06
$-0.64
Q1 24
$0.11
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENK
GENK
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$2.8M
$279.5M
Total DebtLower is stronger
$13.6M
Stockholders' EquityBook value
$26.5M
$5.3M
Total Assets
$259.9M
$784.1M
Debt / EquityLower = less leverage
0.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENK
GENK
PACB
PACB
Q4 25
$2.8M
$279.5M
Q3 25
$4.8M
$298.7M
Q2 25
$9.6M
$314.7M
Q1 25
$15.4M
$343.1M
Q4 24
$23.7M
$389.9M
Q3 24
$22.1M
$471.1M
Q2 24
$29.2M
$509.8M
Q1 24
$28.1M
$561.9M
Total Debt
GENK
GENK
PACB
PACB
Q4 25
$13.6M
Q3 25
$10.8M
Q2 25
$7.8M
Q1 25
$6.5M
Q4 24
$6.9M
Q3 24
$7.2M
Q2 24
$7.6M
Q1 24
$7.7M
Stockholders' Equity
GENK
GENK
PACB
PACB
Q4 25
$26.5M
$5.3M
Q3 25
$38.1M
$36.1M
Q2 25
$41.0M
$61.5M
Q1 25
$42.8M
$91.6M
Q4 24
$44.1M
$506.6M
Q3 24
$46.5M
$453.1M
Q2 24
$45.9M
$492.7M
Q1 24
$40.4M
$649.0M
Total Assets
GENK
GENK
PACB
PACB
Q4 25
$259.9M
$784.1M
Q3 25
$245.5M
$803.2M
Q2 25
$246.3M
$825.5M
Q1 25
$232.4M
$860.8M
Q4 24
$240.4M
$1.3B
Q3 24
$225.7M
$1.5B
Q2 24
$218.8M
$1.5B
Q1 24
$214.5M
$1.7B
Debt / Equity
GENK
GENK
PACB
PACB
Q4 25
0.51×
Q3 25
0.28×
Q2 25
0.19×
Q1 25
0.15×
Q4 24
0.16×
Q3 24
0.16×
Q2 24
0.17×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENK
GENK
PACB
PACB
Operating Cash FlowLast quarter
$-426.0K
$-19.1M
Free Cash FlowOCF − Capex
$-5.6M
$-19.9M
FCF MarginFCF / Revenue
-11.3%
-44.6%
Capex IntensityCapex / Revenue
10.5%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.3M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENK
GENK
PACB
PACB
Q4 25
$-426.0K
$-19.1M
Q3 25
$-1.6M
$-18.7M
Q2 25
$3.3M
$-29.4M
Q1 25
$2.2M
$-44.1M
Q4 24
$7.3M
$-30.6M
Q3 24
$1.4M
$-45.5M
Q2 24
$5.6M
$-54.3M
Q1 24
$3.5M
$-75.7M
Free Cash Flow
GENK
GENK
PACB
PACB
Q4 25
$-5.6M
$-19.9M
Q3 25
$-7.7M
$-18.8M
Q2 25
$-6.3M
$-29.9M
Q1 25
$-4.7M
$-45.4M
Q4 24
$165.0K
$-32.3M
Q3 24
$-6.8M
$-46.3M
Q2 24
$1.2M
$-55.7M
Q1 24
$-586.0K
$-79.6M
FCF Margin
GENK
GENK
PACB
PACB
Q4 25
-11.3%
-44.6%
Q3 25
-15.3%
-48.9%
Q2 25
-11.5%
-75.3%
Q1 25
-8.2%
-122.3%
Q4 24
0.3%
-82.3%
Q3 24
-13.9%
-115.7%
Q2 24
2.3%
-154.8%
Q1 24
-1.2%
-205.0%
Capex Intensity
GENK
GENK
PACB
PACB
Q4 25
10.5%
1.9%
Q3 25
12.0%
0.2%
Q2 25
17.5%
1.4%
Q1 25
11.9%
3.7%
Q4 24
13.1%
4.1%
Q3 24
16.9%
2.0%
Q2 24
8.0%
4.1%
Q1 24
8.1%
10.0%
Cash Conversion
GENK
GENK
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
57.96×
Q2 24
20.06×
Q1 24
7.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENK
GENK

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons